 Avalon GloboCare Corp NASDAQ: AVCO has agreed to acquire Hebei Senlang Biotechnology, dubbed SenlangBio, a China-based cell therapy company, in an all-stock transaction. In connection with the transaction, Avalon will issue 81 million shares of its common stock. 